Waltz Quoted on Findings of New Audit Report From HHS Office of Inspector General
31 August 2020
Report on Medicare Compliance
Partner Judy Waltz was quoted in a Report on Medicare Compliance article, “Extrapolation Takes a Hit in OIG Report; ‘Inconsistency is Disturbing,’” about a new audit report from the HHS Office of Inspector General showing that Medicare administrative contractors and qualified independent contractors weren’t always consistent in the way they evaluate the extrapolation of overpayments during appeals of claim denials.
Waltz said the findings suggest that a lot of extrapolation may be improperly or at least inconsistently calculated. “For a national program, consistency is obviously important, so the fact that there is such identified inconsistency is disturbing, particularly given the financial impact for providers and suppliers,” she said.
(Subscription required.)
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."